Ciba Foundation
| Other Names: |
|
|---|---|
| Corporate Relations: | Novartis Foundation |
| Geographical Relations: | Ort: London Wirkungsraum: Großbritannien Wirkungsraum: Schweiz Country: United Kingdom (XA-GB) Country: Switzerland (XA-CH) |
| Biographical References: | GKD GND (1003913-2)LCAuth |
| Archived Material: | Kalliope |
Newest Titles (by)
- Human embryo research: yes or no?: papers from members of a study group that met at the Ciba Foundation on 6 and 7 Nov. 1985
- Child sexual abuse within the family
- The family and its future: a Ciba Foundation Symposium ; [Symposium on the family and its future held 10. -12. march 1970]
- The mentally abnormal offender
- Transcultural psychiatry
Related Authors
Popular keywords
Abnormalities
1
Care
1
Child molesting
1
Child Sexual Abuse
1
Congresses
3
Dysfunctional families
1
Embryo
1
Embryology
1
Embryonenforschung
1
Familie
2
Family
1
Fertilization in vitro
1
Gentechnologie
1
Human embryo
1
Infertility
1
Kind
1
Moral and ethical aspects
1
Research
1
Services for
1
Sexually abused children
1
Sexueller Missbrauch
1
Social psychiatry
1
Zukunft
1
Congresses
3
Familie
2
Abnormalities
1
Care
1
Child Sexual Abuse
1
Child molesting
1
Dysfunctional families
1
Embryo
1
Embryology
1
Embryonenforschung
1
Family
1
Fertilization in vitro
1
Gentechnologie
1
Human embryo
1
Infertility
1
Kind
1
Moral and ethical aspects
1
Research
1
Services for
1
Sexually abused children
1
Sexueller Missbrauch
1
Social psychiatry
1
Zukunft
1
Publication Timeline
Details
- CIBA-Stiftung
- Ciba Foundation for the Promotion of International Co-operation in Medical and Chemical Research
- Ciba Foundation for the Promotion of International Cooperation in Medical and Chemical Research
MARC
| LEADER | 00000cz a2200000n 4500 | ||
|---|---|---|---|
| 001 | 103024034 | ||
| 003 | DE-627 | ||
| 005 | 20220518211635.0 | ||
| 008 | 120418n||aznnnabbn | ana |c | ||
| 024 | 7 | |a http://d-nb.info/gnd/1003913-2 |2 uri | |
| 035 | |a (DE-588)1003913-2 | ||
| 035 | |a (DE-627)103024034 | ||
| 035 | |z (DE-627)104300337 | ||
| 035 | |a (DE-576)191153516 | ||
| 035 | |z (DE-576)210809779 | ||
| 035 | |z (DE-588c)4286582-7 |9 v:zg | ||
| 035 | |z (DE-588b)1003913-2 |9 v:zg | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 043 | |c XA-GB |c XA-CH | ||
| 065 | |a 27.1a |2 sswd | ||
| 079 | |a g |b b |c v |q f |q s |v kiz | ||
| 110 | 2 | |a Ciba Foundation | |
| 410 | 2 | |a CIBA-Stiftung | |
| 410 | 2 | |a Ciba Foundation for the Promotion of International Cooperation in Medical and Chemical Research | |
| 410 | 2 | |a Ciba Foundation for the Promotion of International Co-operation in Medical and Chemical Research | |
| 510 | 2 | |0 (DE-627)235016888 |0 (DE-576)196600057 |0 (DE-588)5251089-X |a Novartis Foundation |4 nach |w r |i Nachfolger |e Nachfolger | |
| 548 | |a 1949-1996 |4 datb |w r |i Zeitraum | ||
| 550 | |0 (DE-627)104918799 |0 (DE-576)210370602 |0 (DE-588)4233252-7 |a Nichtstaatliche Forschungsförderung |4 obin |w r |i Oberbegriff instantiell | ||
| 550 | |0 (DE-627)106390600 |0 (DE-576)208850341 |0 (DE-588)4003120-2 |a Arzneimittelforschung |4 them |w r |i Thema | ||
| 551 | |0 (DE-627)106089994 |0 (DE-576)209193417 |0 (DE-588)4074335-4 |a London |4 orta |w r |i Ort | ||
| 551 | |0 (DE-627)104665513 |0 (DE-576)208942076 |0 (DE-588)4022153-2 |a Großbritannien |4 geow |w r |i Wirkungsraum | ||
| 551 | |0 (DE-627)104584904 |0 (DE-576)20910614X |0 (DE-588)4053881-3 |a Schweiz |4 geow |w r |i Wirkungsraum | ||
| 670 | |a LCAuth | ||
| 670 | |a GKD | ||
| BEA | |a Kalliope Verbundkatalog |u https://kalliope-verbund.info/gnd/1003913-2 |0 lr | ||
| ORI | |a WA-MARC-krimdokc001.raw | ||
| SUB | |a KRI |b 6 | ||